News | Hologic http://investors.hologic.com/ Hologic to Webcast Presentations at Upcoming Investor Conferences http://investors.hologic.com/2018-02-12-Hologic-to-Webcast-Presentations-at-Upcoming-Investor-Conferences Mon, 12 Feb 2018 08:15:00 -0500 http://investors.hologic.com/2018-02-12-Hologic-to-Webcast-Presentations-at-Upcoming-Investor-Conferences Hologic Announces Financial Results for First Quarter of Fiscal 2018 http://investors.hologic.com/2018-02-08-Hologic-Announces-Financial-Results-for-First-Quarter-of-Fiscal-2018 -- Revenue of $791.1 Million Grows 7.7%, 6.7% in Constant Currency -- Thu, 08 Feb 2018 16:01:00 -0500 http://investors.hologic.com/2018-02-08-Hologic-Announces-Financial-Results-for-First-Quarter-of-Fiscal-2018 Hologic Announces Upcoming Put Option and Notice of Redemption of 2.00% Convertible Senior Notes Due 2042 http://investors.hologic.com/2018-01-29-Hologic-Announces-Upcoming-Put-Option-and-Notice-of-Redemption-of-2-00-Convertible-Senior-Notes-Due-2042 Mon, 29 Jan 2018 16:02:00 -0500 http://investors.hologic.com/2018-01-29-Hologic-Announces-Upcoming-Put-Option-and-Notice-of-Redemption-of-2-00-Convertible-Senior-Notes-Due-2042 Aptima® HBV Quant Assay for Quantitation of Hepatitis B Viral Load Receives PMA Approval http://investors.hologic.com/2018-01-25-Aptima-R-HBV-Quant-Assay-for-Quantitation-of-Hepatitis-B-Viral-Load-Receives-PMA-Approval --Aptima assay portfolio rapidly expanding with the addition of tests to quantitate HIV-1, HCV and HBV now available on the fully automated Panther system-- Thu, 25 Jan 2018 08:17:00 -0500 http://investors.hologic.com/2018-01-25-Aptima-R-HBV-Quant-Assay-for-Quantitation-of-Hepatitis-B-Viral-Load-Receives-PMA-Approval Hologic Launches Fluoroscan® InSight™ FD Mini C-Arm Extremities Imaging System http://investors.hologic.com/Fluoroscan-R-InSight-TM-FD-Mini-C-Arm-Extremities-Imaging-System ---New Innovation Enriches Mini C-Arm Technology with Diversified Imaging Options, Upgraded Storage and Transport, and Enhanced Interface--- Thu, 25 Jan 2018 08:00:00 -0500 http://investors.hologic.com/Fluoroscan-R-InSight-TM-FD-Mini-C-Arm-Extremities-Imaging-System Hologic's Cynosure Division Launches TempSure™ Envi http://investors.hologic.com/2018-01-22-Hologics-Cynosure-Division-Launches-TempSure-TM-Envi --Superior Radiofrequency Treatment Minimizes Fine Facial Lines and Wrinkles, Tightens Skin Through Soft Tissue Coagulation, and Improves the Appearance of Cellulite-- Mon, 22 Jan 2018 09:05:00 -0500 http://investors.hologic.com/2018-01-22-Hologics-Cynosure-Division-Launches-TempSure-TM-Envi Hologic Announces Pricing of Offering of $1 Billion of Senior Notes http://investors.hologic.com/2018-01-16-Hologic-Announces-Pricing-of-Offering-of-1-Billion-of-Senior-Notes Tue, 16 Jan 2018 19:40:00 -0500 http://investors.hologic.com/2018-01-16-Hologic-Announces-Pricing-of-Offering-of-1-Billion-of-Senior-Notes Hologic Announces Offering of $1 Billion of Senior Notes http://investors.hologic.com/2018-01-16-Hologic-Announces-Offering-of-1-Billion-of-Senior-Notes - Proceeds Expected to Contribute to Retirement of All Outstanding 5.25% Senior Notes due 2022 - Tue, 16 Jan 2018 07:54:00 -0500 http://investors.hologic.com/2018-01-16-Hologic-Announces-Offering-of-1-Billion-of-Senior-Notes Aptima® HIV-1 Quant Dx Assay Awarded World Health Organization Prequalification http://investors.hologic.com/news?item=691 Tue, 16 Jan 2018 00:05:00 -0500 http://investors.hologic.com/news?item=691 Namal Nawana Elected to Hologic Board of Directors http://investors.hologic.com/2018-01-11-Namal-Nawana-Elected-to-Hologic-Board-of-Directors Thu, 11 Jan 2018 16:01:00 -0500 http://investors.hologic.com/2018-01-11-Namal-Nawana-Elected-to-Hologic-Board-of-Directors Hologic Announces European CE Mark for Brevera® Breast Biopsy System with CorLumina® Imaging Technology http://investors.hologic.com/Hologic-Announces-European-CE-Mark-for-Brevera-R-Breast-Biopsy-System-with-CorLumina-R-Imaging-Technology --Transformational Workflow Solution Offers Real-Time Imaging of Tissue Samples, Resulting in Major Cost and Time Savings-- Tue, 09 Jan 2018 08:00:00 -0500 http://investors.hologic.com/Hologic-Announces-European-CE-Mark-for-Brevera-R-Breast-Biopsy-System-with-CorLumina-R-Imaging-Technology Hologic to Announce Financial Results for the First Quarter of Fiscal 2018 on Thursday, February 8, 2018 http://investors.hologic.com/2018-01-08-Hologic-to-Announce-Financial-Results-for-the-First-Quarter-of-Fiscal-2018-on-Thursday-February-8-2018 Mon, 08 Jan 2018 07:02:00 -0500 http://investors.hologic.com/2018-01-08-Hologic-to-Announce-Financial-Results-for-the-First-Quarter-of-Fiscal-2018-on-Thursday-February-8-2018 Hologic Preliminary Revenues Increase 8% to Approximately $791 Million in the First Quarter of Fiscal 2018 http://investors.hologic.com/2018-01-08-Hologic-Preliminary-Revenues-Increase-8-to-Approximately-791-Million-in-the-First-Quarter-of-Fiscal-2018 -- Company Expects Non-GAAP Effective Tax Rate of 23% to 24% in Fiscal 2018 -- Mon, 08 Jan 2018 07:00:00 -0500 http://investors.hologic.com/2018-01-08-Hologic-Preliminary-Revenues-Increase-8-to-Approximately-791-Million-in-the-First-Quarter-of-Fiscal-2018 Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2042 are Eligible to Convert http://investors.hologic.com/2018-01-04-Hologic-Delivers-Notice-that-Holders-of-2-00-Convertible-Exchange-Senior-Notes-Due-2042-are-Eligible-to-Convert Thu, 04 Jan 2018 16:01:00 -0500 http://investors.hologic.com/2018-01-04-Hologic-Delivers-Notice-that-Holders-of-2-00-Convertible-Exchange-Senior-Notes-Due-2042-are-Eligible-to-Convert Hologic Receives CE Mark for MyoSure® MANUAL Device in Europe http://investors.hologic.com/2018-01-03-Hologic-Receives-CE-Mark-for-MyoSure-R-MANUAL-Device-in-Europe Wed, 03 Jan 2018 08:00:00 -0500 http://investors.hologic.com/2018-01-03-Hologic-Receives-CE-Mark-for-MyoSure-R-MANUAL-Device-in-Europe Hologic to Present at the 36th Annual J.P. Morgan Healthcare Conference http://investors.hologic.com/2018-01-02-Hologic-to-Present-at-the-36th-Annual-J-P-Morgan-Healthcare-Conference Tue, 02 Jan 2018 18:11:00 -0500 http://investors.hologic.com/2018-01-02-Hologic-to-Present-at-the-36th-Annual-J-P-Morgan-Healthcare-Conference Third Respiratory Assay Now FDA Cleared on Hologic's New Panther Fusion® System http://investors.hologic.com/2017-12-06-Third-Respiratory-Assay-Now-FDA-Cleared-on-Hologics-New-Panther-Fusion-R-System -- New Assay Detects Adenovirus, Human Metapneumovirus and Rhinovirus -- Wed, 06 Dec 2017 08:08:00 -0500 http://investors.hologic.com/2017-12-06-Third-Respiratory-Assay-Now-FDA-Cleared-on-Hologics-New-Panther-Fusion-R-System Hologic Signs Development and Distribution Agreement with Clarius Mobile Health for Innovative Ultrasound System http://investors.hologic.com/2017-11-26-Hologic-Signs-Development-and-Distribution-Agreement-with-Clarius-Mobile-Health-for-Innovative-Ultrasound-System Partnership will help Hologic drive global access to critical breast health services Sun, 26 Nov 2017 09:00:00 -0500 http://investors.hologic.com/2017-11-26-Hologic-Signs-Development-and-Distribution-Agreement-with-Clarius-Mobile-Health-for-Innovative-Ultrasound-System Hologic Receives FDA 510(k) Clearance of Quantra™ 2.2 Breast Density Assessment Software http://investors.hologic.com/2017-11-24-Hologic-Receives-FDA-510-k-Clearance-of-Quantra-TM-2-2-Breast-Density-Assessment-Software --Latest addition to market-leading portfolio of innovative breast and skeletal health solutions to be featured at RSNA 2017-- Fri, 24 Nov 2017 08:05:00 -0500 http://investors.hologic.com/2017-11-24-Hologic-Receives-FDA-510-k-Clearance-of-Quantra-TM-2-2-Breast-Density-Assessment-Software Hologic Announces Upcoming Put Option and Notice of Redemption of 2.00% Convertible Senior Notes Due 2043 http://investors.hologic.com/2017-11-14-Hologic-Announces-Upcoming-Put-Option-and-Notice-of-Redemption-of-2-00-Convertible-Senior-Notes-Due-2043 Tue, 14 Nov 2017 16:01:00 -0500 http://investors.hologic.com/2017-11-14-Hologic-Announces-Upcoming-Put-Option-and-Notice-of-Redemption-of-2-00-Convertible-Senior-Notes-Due-2043 Hologic Announces Financial Results for Fourth Quarter of Fiscal 2017 http://investors.hologic.com/2017-11-08-Hologic-Announces-Financial-Results-for-Fourth-Quarter-of-Fiscal-2017 -- Company Posts Revenue of $802.9 Million, GAAP Diluted EPS of $0.29, and Non-GAAP Diluted EPS of $0.50 -- Wed, 08 Nov 2017 16:01:00 -0500 http://investors.hologic.com/2017-11-08-Hologic-Announces-Financial-Results-for-Fourth-Quarter-of-Fiscal-2017 Hologic to Webcast Presentations at Upcoming Investor Conferences http://investors.hologic.com/2017-11-06-Hologic-to-Webcast-Presentations-at-Upcoming-Investor-Conferences Mon, 06 Nov 2017 08:10:00 -0500 http://investors.hologic.com/2017-11-06-Hologic-to-Webcast-Presentations-at-Upcoming-Investor-Conferences Hologic Launches the MyoSure® MANUAL Device to Help Doctors Remove Intrauterine Tissue In-Office http://investors.hologic.com/2017-11-01-Hologic-Launches-the-MyoSure-R-MANUAL-Device-to-Help-Doctors-Remove-Intrauterine-Tissue-In-Office Wed, 01 Nov 2017 08:07:00 -0400 http://investors.hologic.com/2017-11-01-Hologic-Launches-the-MyoSure-R-MANUAL-Device-to-Help-Doctors-Remove-Intrauterine-Tissue-In-Office Hologic and Tromp Medical to Provide All Mammography Systems for the Dutch Breast Cancer Screening Program http://investors.hologic.com/news?item=675 -- Under the tender, state-of-the-art 3Dimensions™ mammography systems will be installed starting in 2018 -- Wed, 01 Nov 2017 08:00:00 -0400 http://investors.hologic.com/news?item=675 Paraflu Assay Now FDA Cleared on Hologic's New Panther Fusion® System http://investors.hologic.com/2017-10-26-Paraflu-Assay-Now-FDA-Cleared-on-Hologics-New-Panther-Fusion-R-System -- New Assay Extends Respiratory Testing Menu; Modular Panels and Fusion System Increase Efficiency and Flexibility for the Laboratory -- Thu, 26 Oct 2017 08:07:00 -0400 http://investors.hologic.com/2017-10-26-Paraflu-Assay-Now-FDA-Cleared-on-Hologics-New-Panther-Fusion-R-System